Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intravenous Infusions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01907997
What this trial is testing

Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy

Who this might be right for
Thyroid Cancer
Yonsei University 90
Early research (Phase 1)Study completedNCT05085197
What this trial is testing

The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects

Who this might be right for
Healthy
Staidson Biopharma Inc. 32
Large-scale testing (Phase 3)UnknownNCT00058474
What this trial is testing

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

Who this might be right for
Colorectal Cancer
NSABP Foundation Inc 1,608
Large-scale testing (Phase 3)Study completedNCT00056550
What this trial is testing

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.

Who this might be right for
Antithrombin Deficiency, Congenital
rEVO Biologics 14
Early research (Phase 1)Ended earlyNCT03891420
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19

Who this might be right for
COVID-19Yellow Fever
BioCryst Pharmaceuticals 24
Early research (Phase 1)Study completedNCT00000721
What this trial is testing

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Early research (Phase 1)Study completedNCT01983514
What this trial is testing

Effects of Intranasal Administration of a Single Dose of Oxytocin Using a Novel Device in Healthy Adults

Who this might be right for
Healthy Male Adults
OptiNose AS 19
Large-scale testing (Phase 3)Ended earlyNCT01006252
What this trial is testing

Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma

Who this might be right for
Melanoma
Eli Lilly and Company 336
Testing effectiveness (Phase 2)Study completedNCT00998192
What this trial is testing

REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of the Lung
Oncolytics Biotech 32
Testing effectiveness (Phase 2)Study completedNCT07446309
What this trial is testing

Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults

Who this might be right for
Neuromuscular Blockade
Jiangsu HengRui Medicine Co., Ltd. 67
Testing effectiveness (Phase 2)UnknownNCT00024414
What this trial is testing

DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Theradex
Early research (Phase 1)Study completedNCT01769755
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease

Who this might be right for
Crohns Disease
Celularity Incorporated 14
Not applicableStudy completedNCT05835778
What this trial is testing

Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI

Who this might be right for
Biliary Tract Cancer
AstraZeneca 236
Early research (Phase 1)Study completedNCT00513981
What this trial is testing

High-Dose Methotrexate in Treating Young Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Cancer and Leukaemia Group 36
Early research (Phase 1)Study completedNCT05721287
What this trial is testing

A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults

Who this might be right for
PainAcute Pain
Sparian Biosciences, Inc 48
Early research (Phase 1)Study completedNCT01089998
What this trial is testing

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations

Who this might be right for
Diagnostic Imaging
Lantheus Biosciences Ltd. 35
Testing effectiveness (Phase 2)UnknownNCT04551443
What this trial is testing

WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Navy General Hospital, Beijing 200
Testing effectiveness (Phase 2)WithdrawnNCT00313807
What this trial is testing

Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage

Who this might be right for
Contrast NephropathyRenal Failure
Queen's University
Not applicableActive Not RecruitingNCT06864585
What this trial is testing

Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan

Who this might be right for
Infectious Diseases
Pfizer 59
Early research (Phase 1)Ended earlyNCT01035216
What this trial is testing

A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

Who this might be right for
Leukemia
SBI Biotech Co., Ltd. 18
Next Page